Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 9
2005 5
2006 7
2007 4
2008 4
2009 4
2010 5
2011 2
2012 4
2013 6
2014 7
2015 7
2016 4
2017 4
2018 3
2019 4
2020 6
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

82 results
Results by year
Filters applied: . Clear all
Page 1
New markers in prostate cancer: Genomics.
Fuessel S, Wirth MP. Fuessel S, et al. Arch Esp Urol. 2019 Mar;72(2):116-125. Arch Esp Urol. 2019. PMID: 30855012 Free article. Review. English.
Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer.
Dutta S, Polavaram NS, Islam R, Bhattacharya S, Bodas S, Mayr T, Roy S, Albala SAY, Toma MI, Darehshouri A, Borkowetz A, Conrad S, Fuessel S, Wirth M, Baretton GB, Hofbauer LC, Ghosh P, Pienta KJ, Klinkebiel DL, Batra SK, Muders MH, Datta K. Dutta S, et al. Among authors: fuessel s. Oncogene. 2022 Jul;41(30):3747-3760. doi: 10.1038/s41388-022-02382-y. Epub 2022 Jun 27. Oncogene. 2022. PMID: 35754042
Quantification of MicroRNAs in Urine-Derived Specimens.
Fuessel S, Lohse-Fischer A, Vu Van D, Salomo K, Erdmann K, Wirth MP. Fuessel S, et al. Methods Mol Biol. 2018;1655:201-226. doi: 10.1007/978-1-4939-7234-0_16. Methods Mol Biol. 2018. PMID: 28889388
Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer.
Schulz A, Gorodetska I, Behrendt R, Fuessel S, Erdmann K, Foerster S, Datta K, Mayr T, Dubrovska A, Muders MH. Schulz A, et al. Among authors: fuessel s. Front Oncol. 2020 Jan 21;9:1461. doi: 10.3389/fonc.2019.01461. eCollection 2019. Front Oncol. 2020. PMID: 32038994 Free PMC article.
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate Cancer.
Kreuz M, Otto DJ, Fuessel S, Blumert C, Bertram C, Bartsch S, Loeffler D, Puppel SH, Rade M, Buschmann T, Christ S, Erdmann K, Friedrich M, Froehner M, Muders MH, Schreiber S, Specht M, Toma MI, Benigni F, Freschi M, Gandaglia G, Briganti A, Baretton GB, Loeffler M, Hackermüller J, Reiche K, Wirth M, Horn F. Kreuz M, et al. Among authors: fuessel s. Eur Urol. 2020 Sep;78(3):452-459. doi: 10.1016/j.eururo.2020.06.001. Epub 2020 Jul 4. Eur Urol. 2020. PMID: 32631745
Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions.
Keck B, Borkowetz A, Poellmann J, Jansen T, Fischer M, Fuessel S, Kahlmeyer A, Wirth M, Huber J, Cavallaro A, Hammon M, Platzek I, Hartmann A, Baretton G, Kunath F, Sikic D, Taubert H, Wullich B, Erdmann K, Wach S. Keck B, et al. Among authors: fuessel s. Cells. 2021 May 25;10(6):1315. doi: 10.3390/cells10061315. Cells. 2021. PMID: 34070529 Free PMC article.
Role of WNT5A receptors FZD5 and RYK in prostate cancer cells.
Thiele S, Zimmer A, Göbel A, Rachner TD, Rother S, Fuessel S, Froehner M, Wirth MP, Muders MH, Baretton GB, Jakob F, Rauner M, Hofbauer LC. Thiele S, et al. Among authors: fuessel s. Oncotarget. 2018 Jun 5;9(43):27293-27304. doi: 10.18632/oncotarget.25551. eCollection 2018 Jun 5. Oncotarget. 2018. PMID: 29930766 Free PMC article.
82 results